HealthCare21 Communications, a Lucid Group Company

PharmaceuticalsEngland, United Kingdom51-200 Employees

HealthCare21 Communications, based in Macclesfield in North West England, is a mid-sized medical communications agency within the Lucid Group. It supports pharmaceutical companies active in specialty therapeutic areas by developing educational programs and tools tied to long-term progressive conditions. A distinct unit, Medical Education Grants (MEG), collaborates with experts and independent entities to develop digital materials and continuing medical education funded through educational grants that aim to improve medical practice, patient management, and engagement. The firm emphasizes a bespoke, flexible, highly engaged service, delivered by an integrated team that plans, anticipates, and responds to client needs.\n\nIts experience spans Cardio-metabolism, Haemato-oncology, Hepatology, Infectious diseases/vaccines, Neurology, Ophthalmology, Paediatrics/neonatology, Radiology, Rare/orphan diseases, Rheumatology/inflammation/immunology, Transplantation, and Urology, and its activities cover advisory boards, CME, congress reporting, market access planning, market development, medical education, patient education, and related stakeholder initiatives. The organization positions itself in the pharmaceutical manufacturing sector as a provider of scientifically grounded, digitally enabled educational projects that aim to support practical decision making and patient engagement. By being part of the Lucid Group, HealthCare21 Communications operates within a broader corporate network while maintaining a clear focus on strategic medical communications.

Sign up for free to view info

Email Format Employee directory